Skip to content


August 23, 2022 – Nob Hill Therapeutics (NHT), a VIC Technology Venture Development portfolio company, announced today that it has received an HHS phase II grant (up to $1.73M) to develop an inhaled therapy to treat lung fungal infection using an innovative first-of-its-kind dry powder nebulizer delivery platform technology. … Read More >>

May 1, 2022 – Inhalation therapies, despite their prevalence in treating pulmonary diseases and respiratory-related conditions, have numerous setbacks, such as the deposition of aerosolized particles in the upper airway.. Read More >>

February 16, 2022 – This special section marks the launch of the annual Startups to Watch list, a collection of startups New Mexico Inno will keep an eye on in the next 12 months…. Read More >>

November 16, 2021 – Nob Hill Therapeutics has recruited global thought leaders to its Strategic Advisory Board. Albuquerque, NM – Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board…. Read More >>

October 28, 2021 – Nob Hill Therapeutics’ Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday, October 29th at 12:00pm ET… Read More >>

October 19, 2021 – An Albuquerque biotech company says patients can use its technology to deliver medication to patients’ respiratory system with hardly any effort. The startup, Nob Hill Therapeutics, is aiming to commercialize a nebulizer that disaggregates powdered particles, spreading them out.. Read More >>

Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge

September 17, 2021 – Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,… Read More >>

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

April 19, 2021 – Atkins will bring critical insight into the development and commercialization of inhaled medicines. Albuquerque, New Mexico – Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been appointed as its Executive Chairman…. Read More >>

April 15, 2020 – Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic conditions such as dementia, diabetes, heart and respiratory disease, the health impact during traumatic periods such as this is magnified. … Read More >>